Fourth and final issue of GaBI Journal’s seventh volume
Nomenclature for biosimilars; a continuing thorny issue
The need for distinct nomenclature for originator and biosimilar products
US generic prescription drug markets 2004‒2016
Source URL: https://gabi-journal.net/2018-4-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.